Acta Oncologica

Papers
(The H4-Index of Acta Oncologica is 18. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Evaluation of in vitro irradiation setup: Designed for the horizontal beamline at the Danish Centre for Particle Therapy77
Corrigendum: Surgical decision-making following neoadjuvant immunotherapy for dMMR rectal cancer; case reports and review of the literature31
Use of PD-1 inhibitors in patients with end-stage renal disease: safety and clinical outcomes from real-world data31
Capecitabine monotherapy as first-line treatment in advanced HER2-normal breast cancer – a nationwide, retrospective study29
Extensive genomic analysis in patients with KRAS-mutated solid tumors shows high frequencies of concurrent alterations and potential targets but has limited clinical impact27
Real-world evidence on perioperative chemotherapy in localized soft tissue sarcoma of the extremities and trunk wall; a population-based study26
Methylphenidate for treating fatigue in palliative cancer care – effect and side effects in real-world data from a palliative care unit24
Socioeconomic inequality in cancer in the Nordic countries. A systematic review24
ctDNA-guided adjuvant treatment after radical-intent treatment of metastatic spread from colorectal cancer—the first interim results from the OPTIMISE study23
Prediction of plan adaptation in head and neck cancer proton therapy using clinical, radiographic, and dosimetric features23
Benefit finding, posttraumatic growth and health-related quality of life in long-term cancer survivors: a prospective population-based study22
Malignancy rates of salivary gland tumors in Greenlandic Inuit comparable to non-endemic populations; epidemiological mapping of salivary gland tumors 1990–201922
Health-Related Quality of Life in Danish Cancer Survivors Referred to a Late Effects Clinic: A Prospective Cohort Study22
The first decade of the Danish Palliative Care Database: improvements and ongoing challenges in the quality and use of specialised palliative care22
The effect of tinzaparin on biomarkers in FIGO stages III-IV ovarian cancer patients undergoing neoadjuvant chemotherapy – the TABANETOC trial: study protocol for a randomized clinical multicenter tri20
Temporal changes in childhood cancer incidence and survival by stage at diagnosis in Australia, 2000–201720
A study of microRNAs as new prognostic biomarkers in anal cancer patients20
Dosimetric predictors of acute bowel toxicity after Stereotactic Body Radiotherapy (SBRT) in the definitive treatment of localized prostate cancer18
Influence of radiotherapy technique on incidental dose to the whole ventricular system in focal irradiation of nongerminomatous germcell tumours18
Use of 5α-reductase inhibitors and survival of oesophageal and gastric cancer in a nationwide Swedish cohort study18
0.1259241104126